Relative vs. absolute measures of benefit and risk: what's the difference?

被引:64
作者
Citrome, L. [1 ,2 ]
机构
[1] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA
[2] NYU, Sch Med, Dept Psychiat, New York, NY USA
关键词
absolute risk increase; evidence-based medicine; hazard ratio; number needed to harm; number needed to treat; odds ratio; relative risk increase; relative risk ratio; MAJOR DEPRESSIVE DISORDER; DOUBLE-BLIND; ADJUNCTIVE THERAPY; DIABETES-MELLITUS; ARIPIPRAZOLE; MULTICENTER; EFFICACY; MEDICINE; SAFETY;
D O I
10.1111/j.1600-0447.2009.01449.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: When appraising evidence clinicians are confronted with two types of comparisons: ratios, such as relative risk, and absolute differences, such as number needed to treat (NNT) or number needed to harm (NNH). Method: A review of the definition, calculation and interpretation of relative measures such as relative risk, odds ratio and the hazard ratio, and how they are different from absolute measures such as NNT and NNH. Results: Relative and absolute measures provide different perspectives. Ratios can be misleading and exaggerate clinical differences, but NNT can appear to trivialize the risk of potentially important adverse events. Conclusion: There is a need to understand both relative and absolute differences in order to make informed decisions.
引用
收藏
页码:94 / 102
页数:9
相关论文
共 23 条
[1]   Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study [J].
Bauer, Michael ;
Pretorius, Herman W. ;
Constant, Eric L. ;
Earley, Willie R. ;
Szamosi, Johan ;
Brecher, Martin .
JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) :540-549
[2]   The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study [J].
Berman, Robert M. ;
Marcus, Ronald N. ;
Swanink, Rene ;
McQuade, Robert D. ;
Carson, William H. ;
Corey-Lisle, Patricia K. ;
Khan, Arif .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) :843-853
[3]  
Braithwaite W., 1999, ROLE EPIDEMIOLOGY DE
[4]   Compelling or irrelevant? Using number needed to treat can help decide [J].
Citrome, L. .
ACTA PSYCHIATRICA SCANDINAVICA, 2008, 117 (06) :412-419
[5]   Teaching the philosophy and tools of evidence-based medicine: misunderstandings and solutions [J].
Citrome, L. ;
Ketter, T. A. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (03) :353-359
[6]  
CITROME L, 2009, CURR DRUG SAF 0901
[7]  
Citrome Leslie, 2008, Expert Rev Neurother, V8, P1079, DOI 10.1586/14737175.8.7.1079
[8]  
Citrome Leslie, 2009, Diabetes Care, V32, pe74, DOI 10.2337/dc09-0159
[9]   Show Me the Evidence: Now What Do I Do with It? [J].
Citrome, Leslie .
SOUTHERN MEDICAL JOURNAL, 2008, 101 (12) :1197-1197
[10]   Risk of treatment-emergent diabetes Mellitus in patients receiving antipsychotics [J].
Citrome, Leslie L. ;
Holt, Richard I. G. ;
Zachry, Woodie M. ;
Clewell, Jerry D. ;
Orth, Paul A. ;
Karagianis, Jamie L. ;
Hoffmann, Vicki Poole .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (10) :1593-1603